|
|
||||||||
1 Division of Endocrinology, Metabolism and Molecular Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059; 2 ExpressGen, Chicago, Illinois 60612; 3 Glaxo-Wellcome Laboratories, Research Triangle Park, North Carolina 27709
Myostatin mutations in mice and cattle are associated with increased muscularity, suggesting that myostatin is a negative regulator of skeletal muscle mass. To test the hypothesis that myostatin inhibits muscle cell growth, we examined the effects of recombinant myostatin in mouse skeletal muscle C2C12 cells. After verification of the expression of cDNA constructs in a cell-free system and in transfected Chinese hamster ovary cells, the human recombinant protein was expressed as the full-length (375-amino acid) myostatin in Drosophila cells (Mst375D), or the 110-amino acid carboxy-terminal protein in Escherichia coli (Mst110EC). These proteins were identified by immunoblotting and were purified. Both Mst375D and Mst110EC dose dependently inhibited cell proliferation (cell count and Formazan assay), DNA synthesis ([3H]thymidine incorporation), and protein synthesis ([1-14C]leucine incorporation) in C2C12 cells. The inhibitory effects of both proteins were greater in myotubes than in myoblasts. Neither protein had any significant effects on protein degradation or apoptosis. In conclusion, recombinant myostatin proteins inhibit cell proliferation, DNA synthesis, and protein synthesis in C2C12 muscle cells, suggesting that myostatin may control muscle mass by inhibiting muscle growth or regeneration.
myoblast; myotube; growth differentiation factor 8; sarcopenia; growth differentiation factor
This article has been cited by other articles:
![]() |
D. L. Allen, A. S. Cleary, K. J. Speaker, S. F. Lindsay, J. Uyenishi, J. M. Reed, M. C. Madden, and R. S. Mehan Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E918 - E927. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Schakman, H Gilson, and J P Thissen Mechanisms of glucocorticoid-induced myopathy J. Endocrinol., April 1, 2008; 197(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Manceau, J. Gros, K. Savage, V. Thome, A. McPherron, B. Paterson, and C. Marcelle Myostatin promotes the terminal differentiation of embryonic muscle progenitors Genes & Dev., March 1, 2008; 22(5): 668 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N Artaza, R. Singh, M. G Ferrini, M. Braga, J. Tsao, and N. F Gonzalez-Cadavid Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts J. Endocrinol., February 1, 2008; 196(2): 235 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-s. Kim, J. K. Petrella, J. M. Cross, and M. M. Bamman Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: a cluster analysis J Appl Physiol, November 1, 2007; 103(5): 1488 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Antony, J. J. Bass, C. D. McMahon, and M. D. Mitchell Myostatin regulates glucose uptake in BeWo cells Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1296 - E1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Kim, N. K. Bobbili, Y. K. Lee, H. J. Jin, and M. A. Dunn Production of a Polyclonal Anti-Myostatin Antibody and the Effects of In Ovo Administration of the Antibody on Posthatch Broiler Growth and Muscle Mass Poult. Sci., June 1, 2007; 86(6): 1196 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. McKoy, K. A. Bicknell, K. Patel, and G. Brooks Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation Cardiovasc Res, May 1, 2007; 74(2): 304 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Heinemeier, J. L. Olesen, P. Schjerling, F. Haddad, H. Langberg, K. M. Baldwin, and M. Kjaer Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types J Appl Physiol, February 1, 2007; 102(2): 573 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Allen and T. G. Unterman Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors Am J Physiol Cell Physiol, January 1, 2007; 292(1): C188 - C199. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Mendias, J. E. Marcin, D. R. Calerdon, and J. A. Faulkner Contractile properties of EDL and soleus muscles of myostatin-deficient mice J Appl Physiol, September 1, 2006; 101(3): 898 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Kollias, R. L. S. Perry, T. Miyake, A. Aziz, and J. C. McDermott Smad7 promotes and enhances skeletal muscle differentiation. Mol. Cell. Biol., August 1, 2006; 26(16): 6248 - 6260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Welle, K. Bhatt, and C. A. Pinkert Myofibrillar protein synthesis in myostatin-deficient mice Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E409 - E415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Marblestone, S. C. Edavettal, Y. Lim, P. Lim, X. Zuo, and T. R. Butt Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO Protein Sci., January 1, 2006; 15(1): 182 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-s. Kim, J. M. Cross, and M. M. Bamman Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1110 - E1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Jackman and S. C. Kandarian The molecular basis of skeletal muscle atrophy Am J Physiol Cell Physiol, October 1, 2004; 287(4): C834 - C843. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, R. A. Frost, E. Svanberg, and T. C. Vary IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E916 - E926. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huygens, M. A. Thomis, M. W. Peeters, J. Aerssens, R. Janssen, R. F. Vlietinck, and G. Beunen Linkage of myostatin pathway genes with knee strength in humans Physiol Genomics, May 19, 2004; 17(3): 264 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. P. CHARGE and M. A. RUDNICKI Cellular and Molecular Regulation of Muscle Regeneration Physiol Rev, January 1, 2004; 84(1): 209 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xu, G. Wu, Y. Zohar, and S.-J. Du Analysis of myostatin gene structure, expression and function in zebrafish J. Exp. Biol., November 15, 2003; 206(22): 4067 - 4079. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Yarasheski Review Article: Exercise, Aging, and Muscle Protein Metabolism J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2003; 58(10): M918 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reisz-Porszasz, S. Bhasin, J. N. Artaza, R. Shen, I. Sinha-Hikim, A. Hogue, T. J. Fielder, and N. F. Gonzalez-Cadavid Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E876 - E888. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. McCroskery, M. Thomas, L. Maxwell, M. Sharma, and R. Kambadur Myostatin negatively regulates satellite cell activation and self-renewal J. Cell Biol., September 15, 2003; 162(6): 1135 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ma, C. Mallidis, S. Bhasin, V. Mahabadi, J. Artaza, N. Gonzalez-Cadavid, J. Arias, and B. Salehian Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E363 - E371. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. McMahon, L. Popovic, J. M. Oldham, F. Jeanplong, H. K. Smith, R. Kambadur, M. Sharma, L. Maxwell, and J. J. Bass Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E82 - E87. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. McMahon, L. Popovic, F. Jeanplong, J. M. Oldham, S. P. Kirk, C. C. Osepchook, K. W. Y. Wong, M. Sharma, R. Kambadur, and J. J. Bass Sexual dimorphism is associated with decreased expression of processed myostatin in males Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E377 - E381. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Marcell, S. M. Harman, R. J. Urban, D. D. Metz, B. D. Rodgers, and M. R. Blackman Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1159 - E1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rios, I. Carneiro, V. M. Arce, and J. Devesa Myostatin is an inhibitor of myogenic differentiation Am J Physiol Cell Physiol, May 1, 2002; 282(5): C993 - C999. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |